Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 152

1.

Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk from the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study.

Giustino G, Kirtane AJ, Baber U, Généreux P, Witzenbichler B, Neumann FJ, Weisz G, Maehara A, Rinaldi MJ, Metzger C, Henry TD, Cox DA, Duffy PL, Mazzaferri EL, Brodie BR, Stuckey TD, Gurbel PA, Dangas GD, Francese DP, Ozan O, Mehran R, Stone GW.

Am J Cardiol. 2016 Apr 6. pii: S0002-9149(16)30421-0. doi: 10.1016/j.amjcard.2016.03.034. [Epub ahead of print]

PMID:
27131611
2.

Impact of an integrated treatment algorithm based on platelet function testing and clinical risk assessment: results of the TRIAGE Patients Undergoing Percutaneous Coronary Interventions To Improve Clinical Outcomes Through Optimal Platelet Inhibition study.

Chandrasekhar J, Baber U, Mehran R, Aquino M, Sartori S, Yu J, Kini A, Sharma S, Skurk C, Shlofmitz RA, Witzenbichler B, Dangas G.

J Thromb Thrombolysis. 2016 Apr 21. [Epub ahead of print]

PMID:
27100112
3.

Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.

Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, Ariti C, Litherland C, Dangas G, Gibson CM, Krucoff MW, Moliterno DJ, Kirtane AJ, Stone GW, Colombo A, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S.

J Am Coll Cardiol. 2016 Apr 6. pii: S0735-1097(16)01590-4. doi: 10.1016/j.jacc.2016.02.064. [Epub ahead of print]

PMID:
27079334
4.

Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study.

Giustino G, Kirtane AJ, Généreux P, Baber U, Witzenbichler B, Neumann FJ, Weisz G, Maehara A, Rinaldi MJ, Metzger C, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Brodie BR, Stuckey TD, Dangas GD, Francese DP, Litherland C, Mehran R, Stone GW.

Am J Cardiol. 2016 Mar 18. pii: S0002-9149(16)30347-2. doi: 10.1016/j.amjcard.2016.03.001. [Epub ahead of print]

PMID:
27067621
5.

Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions.

Abizaid A, Costa RA, Schofer J, Ormiston J, Maeng M, Witzenbichler B, Botelho RV, Costa JR Jr, Chamié D, Abizaid AS, Castro JP, Morrison L, Toyloy S, Bhat V, Yan J, Verheye S.

JACC Cardiovasc Interv. 2016 Mar 28;9(6):565-74. doi: 10.1016/j.jcin.2015.12.004.

PMID:
27013155
6.

Response to Letter Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study".

Weisz G, Smilowitz NR, Kirtane AJ, Rinaldi MJ, Parvataneni R, Xu K, Stuckey TD, Maehara A, Witzenbichler B, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL Jr, Mehran R, Stone GW.

Circ Cardiovasc Interv. 2016 Mar;9(3):e003530. doi: 10.1161/CIRCINTERVENTIONS.116.003530. No abstract available.

PMID:
26951620
7.

Coronary Angiographic Findings in Acute Ischemic Stroke Patients With Elevated Cardiac Troponin: The Troponin Elevation in Acute Ischemic Stroke (TRELAS) Study.

Mochmann HC, Scheitz JF, Petzold GC, Haeusler KG, Audebert HJ, Laufs U, Schneider C, Landmesser U, Werner N, Endres M, Witzenbichler B, Nolte CH; TRELAS Study Group.

Circulation. 2016 Mar 29;133(13):1264-71. doi: 10.1161/CIRCULATIONAHA.115.018547. Epub 2016 Mar 1.

PMID:
26933082
8.

Relationship Between Platelet Reactivity and Culprit Lesion Morphology: An Assessment from the ADAPT-DES Intravascular Ultrasound Substudy.

Yun KH, Mintz GS, Witzenbichler B, Inaba S, Shimizu T, Metzger DC, Rinaldi MJ, Mazzaferri EL Jr, Duffy PL, Weisz G, Stuckey TD, Brodie BR, Kirtane AJ, Stone GW, Maehara A.

JACC Cardiovasc Imaging. 2016 Feb 10. pii: S1936-878X(15)00883-9. doi: 10.1016/j.jcmg.2015.08.019. [Epub ahead of print]

PMID:
26897675
9.

Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study.

Généreux P, Redfors B, Witzenbichler B, Maehara A, Yadav M, Weisz G, Francese DP, Parvataneni R, Brener SJ, Mehran R, Kirtane AJ, Stone GW.

Catheter Cardiovasc Interv. 2016 Jan 27. doi: 10.1002/ccd.26409. [Epub ahead of print]

PMID:
26813732
10.

Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents).

Kirtane AJ, Parikh PB, Stuckey TD, Xu K, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL Jr, Parvataneni R, Maehara A, Généreux P, Mehran R, Stone GW.

JACC Cardiovasc Interv. 2015 Dec 28;8(15):1978-87. doi: 10.1016/j.jcin.2015.08.032.

PMID:
26738669
11.

Effect of Ischemia Duration and Door-to-Balloon Time on Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction: An Analysis From HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).

Prasad A, Gersh BJ, Mehran R, Brodie BR, Brener SJ, Dizon JM, Lansky AJ, Witzenbichler B, Kornowski R, Guagliumi G, Dudek D, Stone GW.

JACC Cardiovasc Interv. 2015 Dec 28;8(15):1966-74. doi: 10.1016/j.jcin.2015.08.031.

PMID:
26738667
12.
13.

Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES Study.

Dohi T, Maehara A, Witzenbichler B, Rinaldi MJ, Mazzaferri EL Jr, Duffy PL, Weisz G, Neumann FJ, Henry TD, Cox DA, Stuckey TD, Brodie BR, Litherland C, Brener SJ, Kirtane AJ, Mintz GS, Stone GW.

Circ Cardiovasc Interv. 2015 Dec;8(12):e002447. doi: 10.1161/CIRCINTERVENTIONS.114.002447.

PMID:
26643737
14.

Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study).

Schoos MM, Dangas GD, Mehran R, Kirtane AJ, Yu J, Litherland C, Clemmensen P, Stuckey TD, Witzenbichler B, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL Jr, Maehara A, Stone GW.

Am J Cardiol. 2016 Jan 15;117(2):192-200. doi: 10.1016/j.amjcard.2015.10.037. Epub 2015 Nov 6.

PMID:
26639039
15.

Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials.

Yu J, Mehran R, Clayton T, Gibson CM, Brodie BR, Witzenbichler B, Lincoff AM, Deliargyris EN, Gersh BJ, Pocock SJ, Stone GW, Dangas GD.

Catheter Cardiovasc Interv. 2016 Feb 15;87(3):391-400. doi: 10.1002/ccd.26146. Epub 2015 Dec 1.

PMID:
26624854
16.

Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).

Maehara A, Ben-Yehuda O, Ali Z, Wijns W, Bezerra HG, Shite J, Généreux P, Nichols M, Jenkins P, Witzenbichler B, Mintz GS, Stone GW.

JACC Cardiovasc Interv. 2015 Nov;8(13):1704-14. doi: 10.1016/j.jcin.2015.07.024.

PMID:
26585621
17.

Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study.

Nakatani S, Onuma Y, Ishibashi Y, Karanasos A, Regar E, Garcia-Garcia HM, Tamburino C, Fajadet J, Vrolix M, Witzenbichler B, Eeckhout E, Spaulding C, Reczuch K, La Manna A, Spaargaren R, Capodanno D, Van Langenhove G, Verheye S, Serruys PW, van Geuns RJ.

EuroIntervention. 2015 Dec;11(8):885-94. doi: 10.4244/EIJY15M11_01.

18.

Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study.

Weisz G, Smilowitz NR, Kirtane AJ, Rinaldi MJ, Parvataneni R, Xu K, Stuckey TD, Maehara A, Witzenbichler B, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL Jr, Mehran R, Stone GW.

Circ Cardiovasc Interv. 2015 Oct;8(10). pii: e001952. doi: 10.1161/CIRCINTERVENTIONS.114.001952.

PMID:
26458411
19.

Usefulness of the Left Anterior Descending Coronary Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).

Kobayashi N, Maehara A, Brener SJ, Généreux P, Witzenbichler B, Guagliumi G, Peruga JZ, Mehran R, Mintz GS, Stone GW.

Am J Cardiol. 2015 Dec 1;116(11):1658-65. doi: 10.1016/j.amjcard.2015.09.004. Epub 2015 Sep 11.

PMID:
26433272
20.

Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DES.

Brodie BR, Garg A, Stuckey TD, Kirtane AJ, Witzenbichler B, Maehara A, Weisz G, Rinaldi MJ, Neumann FJ, Metzger DC, Mehran R, Parvataneni R, Stone GW.

Circ Cardiovasc Interv. 2015 Oct;8(10). pii: e002568. doi: 10.1161/CIRCINTERVENTIONS.114.002568.

PMID:
26415600
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk